These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 19769467)

  • 1. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
    Yakubov S
    Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M; Cambou JP; Ferrières J; Grenier O; Herrmann MA; Cantet C; Leizorovicz A
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):841-8. PubMed ID: 15521475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of peripheral artery disease and the role of antiplatelet therapy.
    Aronow H; Hiatt WR
    Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of patients at risk of ischemic events for long-term secondary prevention.
    Brassard A
    J Am Acad Nurse Pract; 2009 Dec; 21(12):677-89. PubMed ID: 19958419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.
    Suárez C; Zeymer U; Limbourg T; Baumgartner I; Cacoub P; Poldermans D; Röther J; Bhatt DL; Steg PG;
    Vasc Med; 2010 Aug; 15(4):259-65. PubMed ID: 20724374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
    Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
    Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing vascular risk reduction in the stroke patient with atherothrombotic disease.
    Ovbiagele B
    Med Princ Pract; 2010; 19(1):1-12. PubMed ID: 19996612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the preventive effect of different drugs depend on location of the atherosclerotic process?
    Poredos P; Jezovnik MK
    Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
    Mahoney EM; Wang K; Cohen DJ; Hirsch AT; Alberts MJ; Eagle K; Mosse F; Jackson JD; Steg PG; Bhatt DL;
    Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):38-45. PubMed ID: 20031786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The best of vascular medicine in 2006].
    Mounier-Vehier C; Stephan D; Aboyans V; Beregi JP; Lacroix P; Léger P; Long A; Sevestre MA;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():47-55. PubMed ID: 17405565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment and cost of cardiovascular disease in Australia.
    Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
    Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic atherosclerotic disease and stroke.
    Kronzon I; Tunick PA
    Circulation; 2006 Jul; 114(1):63-75. PubMed ID: 16818829
    [No Abstract]   [Full Text] [Related]  

  • 18. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
    Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
    JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and atherothrombosis: an update on the role of antiplatelet therapy.
    Alexandrov AV; Alagona P
    Int J Stroke; 2008 Aug; 3(3):175-81. PubMed ID: 18705896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherothrombosis: management of patients at risk.
    Mas JL
    Int J Clin Pract; 2005 Apr; 59(4):407-14. PubMed ID: 15853855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.